September 21, 2016
Abeona Therapeutics Licenses Next Generation AAV Gene Therapy Vector Platform
Abeona Therapeutics announces the license of a next generation gene therapy AAV capsid portfolio capable of widespread central nervous system gene transfer.
Read More >